Katrin Mestermann

5PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 26, 2024
Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors.

Katrin Mestermann, Andoni Garitano-Trojaola, Michael Hudecek

|Jul 21, 2022
ROR1-targeting switchable CAR-T cells for cancer therapy.

Haiyong Peng, Thomas Nerreter, Katrin Mestermann

|Jul 21, 2021
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.

Hardikkumar Jetani, Almudena Navarro-Bailón, Marius Maucher

|Jul 05, 2019
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells.

Katrin Mestermann, Theodoros Giavridis, Justus Weber

Pageof 1